Wilson Mark Andrew 4
4 · NEKTAR THERAPEUTICS · Filed Dec 15, 2023
Insider Transaction Report
Form 4
Wilson Mark Andrew
Chief Legal Officer
Transactions
- Award
Stock Option
2023-12-13+325,000→ 325,000 totalExercise: $0.50Exp: 2031-12-12→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]This stock option vests over three years from the date of grant, (December 13, 2023) in equal monthly installments based on continued service.